Zevra Therapeutics (ZVRA) Interest & Investment Income (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Interest & Investment Income of $2.57 million for Q2 2026, up 7.9% from $2.38 million a year earlier but down 28.5% from the prior quarter.
Zevra Therapeutics (ZVRA) Interest & Investment Income (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Zevra Therapeutics was $10.18 million, up 161.2% year-over-year; for FY2025, it came in at $6.95 million, up 219.4% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 139.0% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Interest & Investment Income was $2.18 million in FY2024 (-52.1%), $4.54 million in FY2023 (+200.1%), $1.51 million in FY2022 (+479.7%) and $261,000 in FY2021 (+193.3%).
- Quarterly Interest & Investment Income has run from a low of -$73,000 in Q4 2024 to a high of $3.59 million in Q1 2026 over five years.
- On a year-over-year basis, Interest & Investment Income increased in four of the last six quarters, with growth averaging 231.5%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2023, with growth of 873.8%; the weakest was Q2 2024, with a decline of 82.6%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $3.59 million (Q1 2026), $1.71 million (Q4 2025) and $2.31 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 2.57 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.57 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 543,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 270,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Dec 31, 2023 | 210,000.00 |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 218,000.00 |
| Jun 30, 2022 | 366,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 137,000.00 |
Zevra Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();